Clinical Trial Update: A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating three doses of Dextofisopam in females with Irritable Bowel Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Dextofisopam (Dextofisopam)

Snippet

Sponsor: Pharmos | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED